We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Janus Henderson Global Life Sciences Equity Class I - Accumulation (GBP)

Sell:97.07p Buy:97.07p Change: 0.39p (0.40%)
Prices as at 18 July 2025
Sell:97.07p
Buy:97.07p
Change: 0.39p (0.40%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 18 July 2025
Sell:97.07p
Buy:97.07p
Change: 0.39p (0.40%)
Prices as at 18 July 2025
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 94.04%
UK Equities 3.99%
Other 1.31%
Cash and Equiv. 0.66%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 8.41% USA Pharmaceuticals & Biotechnology
2 UNITEDHEALTH GROUP INCORPORATED 6.82% USA Health Care Providers
3 NOVO NORDISK A/S 4.61% DNK Pharmaceuticals & Biotechnology
4 ASTRAZENECA 3.62% GBR Pharmaceuticals & Biotechnology
5 ABBVIE 3.59% USA Pharmaceuticals & Biotechnology
6 AMGEN 3.22% USA Pharmaceuticals & Biotechnology
7 SANOFI 2.76% FRA Pharmaceuticals & Biotechnology
8 MERCK & CO INC(NEW) 2.55% USA Pharmaceuticals & Biotechnology
9 BOSTON SCIENTIFIC CORPORATION 2.50% USA Medical Equipment & Services
10 JOHNSON & JOHNSON 2.47% USA Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account